BioSpace News Archive

Data from the IMROZ phase 3 study demonstrated Sarclisa in combination with standard-of-care bortezomib, lenalidomide and dexamethasone followed by Sarclisa-Rd significantly reduced the risk of disease progression or death by 40%, compared to VRd followed by Rd in patients with newly diagnosed multiple myeloma not eligible for transplant.

Structure Therapeutics Inc. announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed underwritten public offering of 8,000,000 American depositary shares, each representing three ordinary shares.

Terns Pharmaceuticals, Inc. announced that it has granted equity inducement awards to two new employees under the terms of the 2022 Employment Inducement Award Plan, as amended.

OmniAb, Inc. announced the publication of a peer-reviewed paper titled “Chickens with a Truncated Light Chain Transgene Express Single-Domain H Chain-Only Antibodies” in the Journal of Immunology demonstrating that chickens can be genetically engineered to produce functional heavy chain-only single-domain antibodies.

Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target biological pathways associated with specific clinical impairments for the treatment of neuroscience, inflammation and immunology indications, announced the appointment of John Healy as General Counsel & Corporate Secretary.

Hyperfine, Inc., the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance brain imaging system—the Swoop® system— announced it will host an analyst and investor education webcast at 2:00 PM Eastern Time on Tuesday, June 25, 2024, focusing on clinical developments in ultra-low-field MR imaging.

Tectonic Therapeutic, Inc. today announced the appointment of Daniel Lochner as Chief Financial Officer of Tectonic.

Fortrea, a leading global contract research organization, announced that Chairman and Chief Executive Officer, Tom Pike and Chief Financial Officer, Jill McConnell will present at the Jefferies Global Healthcare Conference on Wednesday, June 5, 2024 at 11:00 am ET.